Results 101 to 110 of about 17,469 (199)

Stable overexpression of native and artificial miRNAs for the production of differentially fucosylated antibodies in CHO cells

open access: yesEngineering in Life Sciences
Cell engineering strategies typically rely on energy‐consuming overexpression of genes or radical gene‐knock out. Both strategies are not particularly convenient for the generation of slightly modulated phenotypes, as needed in biosimilar development of ...
Patrick Schlossbauer   +8 more
doaj   +1 more source

Biomolecular Fingerprint of Crohn's Disease: A Comparative Raman Spectroscopic Study of Blood and Tissue Samples

open access: yesJournal of Biophotonics, Volume 19, Issue 1, January 2026.
Raman spectroscopy is evaluated as a minimally invasive tool for diagnosing and monitoring Crohn's disease. Correlation between plasma and tissue spectra indicates that plasma measurements reflect local intestinal inflammation, while therapy‐associated biochemical shifts toward healthy profiles highlight its potential for disease monitoring and ...
M. Daniyal Ghauri   +11 more
wiley   +1 more source

Soluble selectins and highly fucosylated ?1-antichymotrypsin in rheumatoid arthritis patients

open access: yesJournal of Medical Science, 2015
Introduction. Fucosylation of acute phase proteins and serum soluble selectin levels is increased in rheumatoid arthritis (RA) patients and can influence leukocyte extravasation. Aim.
Anna Olewicz-Gawlik   +2 more
doaj   +1 more source

CDG due to Defective Membrane Transporters: Update

open access: yesJournal of Inherited Metabolic Disease, Volume 49, Issue 1, January 2026.
ABSTRACT Congenital disorders of glycosylation are genetic defects in the glycoprotein and glycolipid glycan assembly and attachment. Some 200 CDG have been reported since the first clinical description in 1980. Most CDG are enzymatic deficiencies, but 13 (6.5%) are defects in the ER, Golgi apparatus (GA), and plasma membrane transporters.
D. Quelhas, C. R. Ferreira, J. Jaeken
wiley   +1 more source

MET Enhances Amivantamab Binding to EGFR and Antibody‐Dependent Cellular Toxicity

open access: yesCancer Science, Volume 117, Issue 1, Page 118-129, January 2026.
Amivantamab binds to EGFR domain 3 and the MET Sema domain, and the EGFR‐MET‐amivantamab trimer was successfully visualized using high‐speed atomic force microscopy (HS‐AFM). MET enhances the binding of amivantamab to EGFR and increases antibody‐dependent cellular cytotoxicity (ADCC) even at low concentrations of amivantamab.
Shigeki Sato   +17 more
wiley   +1 more source

Robinia pseudoacacia L. Flower Exosome‐Like Nanoparticles (RFELNs) Activate AhR/IL‐22 to Relieve Intestinal Barrier Dysfunction Through Regulating Gut Microbiota‐Interrelated Tryptophan Metabolism in Ulcerative Colitis Mice

open access: yesMediators of Inflammation, Volume 2026, Issue 1, 2026.
Background Intestinal barrier dysfunction is a key driver of ulcerative colitis (UC) recurrence and chronic persistence. Modulating group 3 innate lymphoid cells (ILC3) activity and tryptophan‐derived metabolites is crucial for enhancing mucosal repair in UC. Robinia pseudoacacia L. flower exosome‐like nanoparticles (RFELNs) could ameliorate intestinal
Feihan Shen   +8 more
wiley   +1 more source

A plant cell‐based platform for the expression of complex proteins with fucose‐reduced sialylated N‐glycans

open access: yes
Plant Biotechnology Journal, EarlyView.
Saeideh Dianatkhah   +10 more
wiley   +1 more source

N-Glycomic and Transcriptomic Changes Associated with CDX1 mRNA Expression in Colorectal Cancer Cell Lines

open access: yesCells, 2019
The caudal-related homeobox protein 1 (CDX1) is a transcription factor, which is important in the development, differentiation, and homeostasis of the gut.
Stephanie Holst   +4 more
doaj   +1 more source

Insights into fucose metabolism: SLC35C1-independent fucosylation discriminates against mannose-derived GDP-fucose [PDF]

open access: green, 2021
Edyta Skurska   +5 more
openalex   +1 more source

Novel insight into FCSK‐congenital disorder of glycosylation through a CRISPR‐generated cell model

open access: yesMolecular Genetics & Genomic Medicine
Background FCSK‐congenital disorder of glycosylation (FCSK‐CDG) is a recently discovered rare autosomal recessive genetic disorder with defective fucosylation due to mutations in the fucokinase encoding gene, FCSK.
Maryam Fazelzadeh Haghighi   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy